# Key Points from IRC Log

• A user inquired about culturing bacteriophages to extract endolysins for treating chronic eczema, with kanzure offering to fund bacteriophage research work.

• kanzure shared a proposal for creating nootropics using brain parasites that can migrate to specific brain regions, create cysts, and potentially excrete beneficial substances in the brain.

• Several scientific papers were shared, including research on tau reduction preventing neuronal loss in mice with tauopathy, taste and smell receptors in lungs, and direct cytosolic delivery of CRISPR/Cas9 for efficient gene editing.

• An article about Trump's opportunity to speed up FDA drug approval processes was shared and discussed positively by one user.

• Several biotech startups from IndieBio accelerator were mentioned, including companies working on DNA data storage, microbiome testing for animals, enzyme optimization, rTMS technology, and microfluidics platforms.

• A paper on gold nanoparticle-based CRISPR/Cas9 delivery with 90% effective recombination in vitro was highlighted as a significant advancement in gene editing technology.

• Links to wiki resources on gene editing, gene therapy, and genetic modifications were shared for community reference.